• Holder: Highbridge Capital Management
• Stake: now 4.98% (about $2M)
• Note: counts convertible securities
• Filed: Nov 16 · Schedule 13G/A
📊 More at www.elixstocks.com
Educational only. Not investment advice.
#Investing #Stocks
• Holder: Highbridge Capital Management
• Stake: now 4.98% (about $2M)
• Note: counts convertible securities
• Filed: Nov 16 · Schedule 13G/A
📊 More at www.elixstocks.com
Educational only. Not investment advice.
#Investing #Stocks
At what market price would buying or selling $INMB make sense to you?
#INMB
At what market price would buying or selling $INMB make sense to you?
#INMB
www.biopharmcatalyst.com/news/2026/bi...
https://www.stocktitan.net/news/INMB/i-nmune-bio-inc-announces-third-quarter-2026-results-and-provides-26vnvgm39z2e.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/INMB/i-nmune-bio-inc-announces-third-quarter-2026-results-and-provides-26vnvgm39z2e.html?utm_source=stocktitan-bluesky&utm_medium=social
On October 28, 2026, the Company issued a press release announcing the pricing of the Offering.
On October 28, 2026, the Company issued a press release announcing the pricing of the Offering.
https://www.stocktitan.net/news/INMB/i-nmune-bio-inc-to-report-third-quarter-2026-financial-results-and-7urzcjrijgt6.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/INMB/i-nmune-bio-inc-to-report-third-quarter-2026-financial-results-and-7urzcjrijgt6.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/INMB/i-nmune-bio-inc-announces-pricing-of-4-50-million-registered-direct-s4hdwxeh2myj.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/INMB/i-nmune-bio-inc-announces-pricing-of-4-50-million-registered-direct-s4hdwxeh2myj.html?utm_source=stocktitan-bluesky&utm_medium=social
INmune Bio submits Ebstrocel pre-MAA to UK MHRA, targets approval in mid-2027
#SEC #stocks #investing #INMB #Regulatory
🔗 secwatch.observer
INmune Bio submits Ebstrocel pre-MAA to UK MHRA, targets approval in mid-2027
#SEC #stocks #investing #INMB #Regulatory
🔗 secwatch.observer
INmune Bio Inc. has prepared a slide deck that the Company intends to use in presentations from time to time . The Presentation is furnished as Exhibit 99.3 to this Current Report on Form 8-K. The information in this Item 7.01 and Exhibit 99.3 of this Current Report on Form 8-K is furnish...
INmune Bio Inc. has prepared a slide deck that the Company intends to use in presentations from time to time . The Presentation is furnished as Exhibit 99.3 to this Current Report on Form 8-K. The information in this Item 7.01 and Exhibit 99.3 of this Current Report on Form 8-K is furnish...
https://www.stocktitan.net/news/INMB/i-nmune-bio-advances-ebstrocel-tm-toward-potential-uk-approval-in-vafqgqkg5pdc.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/INMB/i-nmune-bio-advances-ebstrocel-tm-toward-potential-uk-approval-in-vafqgqkg5pdc.html?utm_source=stocktitan-bluesky&utm_medium=social
INmune Bio disclosed via two press releases and a slide deck (furnished under Reg FD) that it has signed a Master Services Agreement with Uniphar Durbin Ireland Limited to support international access, distribution and commercialization of Ebstrocel™ (CORDStr...
🧵 continued ↓
INmune Bio disclosed via two press releases and a slide deck (furnished under Reg FD) that it has signed a Master Services Agreement with Uniphar Durbin Ireland Limited to support international access, distribution and commercialization of Ebstrocel™ (CORDStr...
🧵 continued ↓
https://www.stocktitan.net/news/INMB/i-nmune-bio-establishes-global-commercialization-framework-for-5j7uh08nyjp7.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/INMB/i-nmune-bio-establishes-global-commercialization-framework-for-5j7uh08nyjp7.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/INMB/i-nmune-bio-inc-and-quantum-computing-inc-partner-to-apply-quantum-7q2gwl6vj13y.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/INMB/i-nmune-bio-inc-and-quantum-computing-inc-partner-to-apply-quantum-7q2gwl6vj13y.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/INMB/i-nmune-bio-to-attend-the-2026-maxim-growth-hit5tgka0bv5.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/INMB/i-nmune-bio-to-attend-the-2026-maxim-growth-hit5tgka0bv5.html?utm_source=stocktitan-bluesky&utm_medium=social
Clark Ronnie Duane () reported special transactions (Non-P/S).
Clark Ronnie Duane () reported special transactions (Non-P/S).
Clark Ronnie Duane () filed Form 3 reporting no initial stock ownership.
Clark Ronnie Duane () filed Form 3 reporting no initial stock ownership.